Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2010
03/30/2010CA2176183C 3-substituted oxindole derivatives as potassium channel modulators
03/25/2010WO2010032408A1 Vaccine preparation for neospora caninum infection
03/25/2010WO2010031852A1 Novel estrogen receptor ligands
03/25/2010WO2010031262A1 A glycoprotein composition almost containing no subunit and preparation method thereof
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076088 Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/25/2010US20100076010 Alpha 1a-adrenoceptor antagonists
03/25/2010US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075982 Pyridinone Derivative For The Treatment of Premature Ejaculation
03/25/2010US20100075912 Novel morphine derivatives
03/24/2010EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells
03/24/2010CN101679470A Method for production of sugar oxazoline derivative
03/24/2010CN101679455A New progesterone receptor modulators
03/24/2010CN101679271A Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases
03/24/2010CN101678114A Solid dosage forms
03/24/2010CN101678062A Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
03/24/2010CN101677980A Use of oligomers of lactic acid in the treatment of gynaecological disorders
03/24/2010CN101676284A Preparation method of nifuratel with high purity
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100594935C Antibodies that immunospecifically bind to trail receptors
03/24/2010CN100594932C Tumor necrosis factor antagonists and their use in endometriosis
03/24/2010CN100594920C Kidney-replenishing sperm-supplementing granule
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683047 Treatment of conditions relating to hormone deficiencies by administration of progestins
03/23/2010CA2356737C Tumor necrosis factor antagonists and their use in endometriosis
03/18/2010WO2010029497A1 Treatment of endometriosis
03/18/2010WO2010028770A1 A chemodenervating agent to introduce temporal infertility in a vertebrate (e.g. human)
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010US20100069474 Novel coumarin derivatives as ion channel openers
03/18/2010US20100069416 Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors
03/18/2010US20100069397 Sexual dysfunction compounds
03/18/2010US20100069387 IKK Inhibitors for the Treatment of Endometriosis
03/18/2010US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069377 Treatment of female sexual dysfunction by compounds that positively modulate ampa-type glutamate receptors
03/18/2010US20100069339 Novel method of treatment of male sub-fertility
03/18/2010US20100068273 Pharmaceutical formulation, its use, and method for its manufacture
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163254A1 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
03/17/2010EP2162189A1 Methods of restoration of erectile function
03/17/2010EP1572214B1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
03/17/2010EP1455847B1 Feminine care products for the delivery of therapeutic substances
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010CN101671618A Penes wine and preparation method thereof
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671339A Citric acid alidenafil crystal form B and preparation method and usage thereof
03/17/2010CN101671338A Citric acid alidenafil crystal form D and preparation method and usage thereof
03/17/2010CN101671337A Citric acid aildenafil crystal form A and preparation method and usage thereof
03/17/2010CN101671260A Method for preparing O-desmethyl-venlafaxine
03/17/2010CN101670086A Chinese medicinal health wine
03/17/2010CN101670067A Medicament for treating endometriosis and preparation process thereof
03/17/2010CN101670064A Compound Chinese medicament for treating endometriosis
03/17/2010CN101670034A Application of traditional Chinese drug Zengshengping to treating mammary gland tumor
03/17/2010CN101670023A Medicament for treating hyperprolactinemia, preparation method thereof and use thereof
03/17/2010CN101670021A Traditional Chinese medicine composite for treating egg laying performance reduction of layer and preparation method thereof
03/17/2010CN101670020A Composition for treating premenstrual syndrome
03/17/2010CN101669981A Method for extracting hydroxyl naphthoquinone total pigment with supercritical carbon dioxide
03/17/2010CN101669966A Piggy injection asexualization method
03/17/2010CN101669900A Polymeric delivery formulations of leuprolide with improved efficacy
03/17/2010CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof
03/17/2010CN100593978C Health food for pregnant woman contaning pearl shell as primary component and its preparing process
03/16/2010US7678787 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/11/2010WO2010027294A1 Composition for treating dysplastic changes in the uterine cervix
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026993A1 Method for improving absorbability of preparation, and preparation having improved absorbability
03/11/2010WO2010026487A1 Therapeutic methods and compositions
03/11/2010WO2010025548A1 Sperm fertility biomarkers and uses thereof
03/11/2010WO2009149411A3 Method of quantification of multiple bioactives from botanical compositons
03/11/2010US20100063120 Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063064 3-(4-Fluoro-2-methyl-phenyl)-6-[5-methoxymethyl-4-(6-methoxy-pyridin-3-yl)-4H-[1,2,4]triazol-3-yl]-pyridazine; treatment of male sexual dysfunction, female sexual dysfunction, hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, sexual pain disorder, or premature ejaculation
03/11/2010US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/11/2010US20100063019 Low Dose Estrogen Interrupted Hormone Replacement Therapy
03/11/2010US20100062055 Lipid-based nitric oxide donors
03/11/2010US20100062039 Intravaginal Ringed Mesh Device And Applicator Therefor
03/11/2010US20100061972 Method of Treating Peyronie's Disease
03/11/2010DE202009016374U1 Formulierung für Frauen im Klimakterium, in der chirurgisch bedingten Menopause oder während einer GnRH-Behandlung Formulation for women in menopause, surgically induced menopause in or during GnRH treatment
03/11/2010CA2734588A1 Silver ion delivery platform
03/10/2010EP2161282A1 Peptide analogues of PACAP
03/10/2010EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
03/10/2010EP2161265A2 Compounds having selective inhibiting effect at GSK3
03/10/2010EP2161033A1 A chemodenervating agent to introduce temporal infertiliy in a vertebrate (e.g. human)
03/10/2010EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/09/2010US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
03/09/2010CA2424346C Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
03/09/2010CA2342960C G protein-coupled receptor antagonists
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010023222A1 Administration unit comprising lactic acid bacteria
03/04/2010US20100056624 Animal model for perimenopause and menopause and methods of inducing ovarian failure
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 557